Globus Medical Inc (GMED)
81.10
0.00 (0.00%)
USD |
NYSE |
Nov 15, 16:00
81.18
+0.08
(+0.10%)
After-Hours: 20:00
Globus Medical Research and Development Expense (TTM): 182.60M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 182.60M |
| June 30, 2024 | 176.55M |
| March 31, 2024 | 160.20M |
| December 31, 2023 | 124.01M |
| September 30, 2023 | 91.26M |
| June 30, 2023 | 80.64M |
| March 31, 2023 | 76.68M |
| December 31, 2022 | 73.02M |
| September 30, 2022 | 104.53M |
| June 30, 2022 | 101.68M |
| March 31, 2022 | 99.83M |
| December 31, 2021 | 97.35M |
| September 30, 2021 | 61.56M |
| June 30, 2021 | 60.13M |
| March 31, 2021 | 84.04M |
| December 31, 2020 | 84.52M |
| September 30, 2020 | 84.77M |
| June 30, 2020 | 84.86M |
| March 31, 2020 | 61.15M |
| December 31, 2019 | 60.07M |
| September 30, 2019 | 58.34M |
| June 30, 2019 | 59.36M |
| March 31, 2019 | 57.13M |
| December 31, 2018 | 55.50M |
| September 30, 2018 | 53.15M |
| Date | Value |
|---|---|
| June 30, 2018 | 48.51M |
| March 31, 2018 | 45.70M |
| December 31, 2017 | 43.68M |
| September 30, 2017 | 45.91M |
| June 30, 2017 | 45.29M |
| March 31, 2017 | 45.17M |
| December 31, 2016 | 44.53M |
| September 30, 2016 | 40.56M |
| June 30, 2016 | 39.55M |
| March 31, 2016 | 38.03M |
| December 31, 2015 | 36.66M |
| September 30, 2015 | 34.87M |
| June 30, 2015 | 33.77M |
| March 31, 2015 | 32.38M |
| December 31, 2014 | 31.17M |
| September 30, 2014 | 29.70M |
| June 30, 2014 | 28.12M |
| March 31, 2014 | 27.47M |
| December 31, 2013 | 26.87M |
| September 30, 2013 | 27.68M |
| June 30, 2013 | 28.13M |
| March 31, 2013 | 28.04M |
| December 31, 2012 | 27.93M |
| September 30, 2012 | 26.47M |
| June 30, 2012 | 25.36M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
60.07M
Minimum
Dec 2019
182.60M
Maximum
Sep 2024
97.47M
Average
84.82M
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp | 1.519B |
| ResMed Inc | 311.34M |
| Haemonetics Corp | 60.10M |
| Abbott Laboratories | 2.795B |
| Stryker Corp | 1.458B |